Podcasts about GLP

You may have heard of Ozempic, and other GLP-1 drugs. They're everywhere. And they typically involve weekly injections — which can have a sticker price of over a thousand dollars a month. And insurance coverage has been tricky to navigate for a lot of people. That's why there's a lot of excitement around a new pill form of the drug. NPR Pharmaceuticals Correspondent Sydney Lupkin chats about these experimental pills with host Emily Kwong. Check out more of NPR's coverage about GLP-1s.Interested in more health stories? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Gary Gaul is a naturopath, biohacker, peptide entrepreneur and is the CEO of CanLab International LLC -a company specializing in high-purity research peptides and bioregulators aimed at performance enhancement, recovery, and longevity in the biohacking community. Gary promotes advanced peptide science and products popular among biohackers for optimizing health and anti-aging. In this episode, we talk abotu peptides and their applications in health and longevity. Gary Gaul and Tara discuss GLP-1 peptides, how age influences the effectiveness and selection of various peptides, how peptides can be used in treating injuries, the "free" peptides available to everyone, peptide quality and reliability. We touch on professional integrity within the peptide industry, ethical practices and transparency.    RESOURCES: Use coupon code COACHTARA to order here: https://canlabintl.com/?ref=2493 Instagram: @officialgarygaul Get 15% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 0:00 Intro 4:40 GLP-1 13:30 The age factor in peptides 21:20 Peptides for injuries 30:00 "Free" peptides 34:00 Peptides quality 51:30 Professional integrity 59:00 A special offer for the podcast listeners   WORK WITH ME: Are You Looking for Help on Your Wellness Journey? Here's how I can help you: TRY COACH TARA APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv   If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the 'Ratings & Reviews' section. Tap 'Write a Review' (you may be prompted to log in with your Apple ID). Thank you!

In this special bonus episode closing out Season 11 of The Remarkable Retail Podcast and the year 2025, hosts Steve Dennis & Michael LeBlanc complete the second half of their annual predictions review—one of the most popular and anticipated episodes of the year. The episode opens with brief but timely discussion on two high-profile retail-adjacent experiences. First us Dennis shares insights from Amazon's first-ever grocery analyst day in Seattle, offering a clearer picture of the company's “one grocery” vision and it's already substantial online presence, now being accelerated as they invest in same day deliver of perishable items.The conversation then turns to Netflix House, following Dennis's visit to the newly opened Dallas location, the second of three that are planned. Positioned in a former department store anchor, Netflix House blends immersive experiences, branded merchandise, gaming, and a restaurant. While customer traffic was encouraging, Dennis offered a frank critique of execution, citing confusing layouts, weak wayfinding, and inconsistent merchandising. The takeaway is cautiously optimistic: the concept has potential, but it is not yet operating at the level that would warrant significant expansion.The core of the episode is Part 2 of Dennis' annual predictions reckoning. Dennis revisits his forecast that department stores would continue “running to stand still,” awarding himself an A-minus as most banners remain stuck in negative or flat comps with limited progress on profitability. His prediction of significant change at Target earns a B-plus, correctly anticipating leadership transitions and the end of the Ulta partnership, though anticipated store closures did not materialize.Dennis also scores highly on his prediction that store closures would once again exceed store openings in the U.S., driven by bankruptcies and retrenchment across drugstores, mid-market apparel, and specialty retail. Predictions around Amazon's physical grocery strategy are largely validated, while expectations for a surge in retail dealmaking and IPO activity fall short, earning a candid C-minus.The episode closes with a nuanced reassessment of the so-called “Ozempic recession.” While the term itself overstated the impact, Dennis and LeBlanc agree that GLP-1 drugs are reshaping consumption patterns—particularly in food, alcohol, and apparel—with long-term implications retailers can no longer ignore.  SPECIAL OFFER for our listeners! SAVE 20% on registration for the all new Shoptalk Luxe event in Abu Dhabi January 27-29.For more info go to https://luxe.shoptalk.com/page/get-ticket and then register using our special code : RRLUXE20 About UsSteve Dennis is a strategic advisor and keynote speaker focused on growth and innovation, who has also been named one of the world's top retail influencers. He is the bestselling authro of two books: Leaders Leap: Transforming Your Company at the Speed of Disruption and Remarkable Retail: How To Win & Keep Customers in the Age of Disruption. Steve regularly shares his insights in his role as a Forbes senior retail contributor and on social media.Michael LeBlanc is the president and founder of M.E. LeBlanc & Company Inc, a senior retail advisor, keynote speaker and now, media entrepreneur. He has been on the front lines of retail industry change for his entire career. Michael has delivered keynotes, hosted fire-side discussions and participated worldwide in thought leadership panels, most recently on the main stage in Toronto at Retail Council of Canada's Retail Marketing conference with leaders from Walmart & Google. He brings 25+ years of brand/retail/marketing & eCommerce leadership experience with Levi's, Black & Decker, Hudson's Bay, CanWest Media, Pandora Jewellery, The Shopping Channel and Retail Council of Canada to his advisory, speaking and media practice.Michael produces and hosts a network of leading retail trade podcasts, including the award-winning No.1 independent retail industry podcast in America, Remarkable Retail with his partner, Dallas-based best-selling author Steve Dennis; Canada's top retail industry podcast The Voice of Retail and Canada's top food industry and one of the top Canadian-produced management independent podcasts in the country, The Food Professor with Dr. Sylvain Charlebois from Dalhousie University in Halifax.Rethink Retail has recognized Michael as one of the top global retail experts for the fourth year in a row, Thinkers 360 has named him on of the Top 50 global thought leaders in retail, RTIH has named him a top 100 global though leader in retail technology and Coresight Research has named Michael a Retail AI Influencer. If you are a BBQ fan, you can tune into Michael's cooking show, Last Request BBQ, on YouTube, Instagram, X and yes, TikTok.Michael is available for keynote presentations helping retailers, brands and retail industry insiders explaining the current state and future of the retail industry in North America and around the world.

The Menopause Solution with Dr. Lauren Fitzgerald What was the black box warning? Why was it there? Why is it now gone? (2:09) An interesting symptom of perimenopause. (8:12) Progesterone will change your life! (9:52) The importance of monitoring your thyroid levels and the 10 most common low-thyroid symptoms. (14:20) Testosterone for women. (22:57) Her main issue with primary care doctors. (27:14) The role of peptides in her practice. (30:01) The buy-in. (30:47) Ranking the various applications of testosterone. (33:39) The BIG myths surrounding HRT. (36:03) It's not a business, it's a mission. (40:26) GLP-1s: Incredible tools when used appropriately. (41:40) Normal isn't OPTIMAL. (45:27) The missing element for MOST people. (55:51) Related Links/Products Mentioned Visit Pre-Alcohol by ZBiotics for an exclusive offer for Mind Pump listeners! ** Promo code MINDPUMP25 for 15% off first-time purchasers on either one-time purchases (3, 6, 12-packs) or subscriptions (6, 12-pack) ** MAPS 15 FORTY PLUS 50% half from Dec. 14-20th. Code DECEMBER50 at checkout. Mind Pump Store FDA to Remove 'Black Box' Warnings From Menopause Hormone Therapy. Here's Why. The WHI Study: How Misinterpretation of Hormone Therapy Data Hurt Women's Health Welcome to the 'menodivorce'. Why women aren't sweating marriage in a sea of hot flashes Estrogen Matters: Why Taking Hormones in Menopause Can Improve and Lengthen Women's Lives -- Without Raising the Risk of Breast Cancer Mind Pump #2502: Hormone Therapy for Aesthetics With Dr. Lauren Fitzgerald Mind Pump #2597: Before You Take Ozempic, Wegovy, or Mounjaro Listen to This! Muscle Mommy Movement Mind Pump Podcast – YouTube Mind Pump Free Resources Featured Guest/People Mentioned LAUREN FITZ, M.D. (@drlaurenfitz) Instagram Website Dr. William Seeds (@williamseedsmd) Instagram Peter Attia, M.D. (@peterattiamd) Instagram

This Week In Startups is made possible by:LinkedIn Ads- http://linkedin.com/thisweekinstartupsSquarespace - https://squarespace.com/twistEnterpret - http://Enterpret.com/twistToday's show: How do top tech CEOs hire? AI has thrown out the playbook for getting hired — so what are the most innovative firms looking for? Anyone can learn any skill and automate much of it, what is to be valued in the modern labor market?On our first AI Roundtable episode of TWiST, Jason is joined by three top tech CEOs: Wade Foster (Zapier), Mikey Schulman (Suno), and Ali Ansari (Micro1). They each give their perspective on the tech talent wars and how to get hired in 2026.The resounding answer on how to get a job? JUST START DOING THE JOB! If you want to be a designer, start sending designs to companies you want to be hired by — don't just sit around waiting to be hired. The biggest value you can bring is a “high agency” mindset to your company and the role. Show you get after it!They are also hitting on:- How AI is getting used to make music today- The tech industry's communication problem- How to raise kids in the age of AITimestamps:(00:00) It's our first ever “This Week in AI” Roundtable, and we've got an amazing panel(05:50) How Meta and OpenAI skew how everyone thinks about compensation(09:37) The importance of looking beyond SF for talent(10:24) LinkedIn Ads: Start converting your B2B audience into high quality leads today. Launch your first campaign and get $250 FREE when you spend at least $250. Go to http://linkedin.com/thisweekinstartups to claim your credit.(14:39) Is AI making more people seek out developer jobs?(18:36) Squarespace - Use offer code TWIST to save 10% off your first purchase of a website or domain at https://squarespace.com/twist(19:36) When design becomes its own bottleneck… and some workarounds.(22:37) It's not how much you know, it's how adaptable you are(24:10) The best way to get hired: just start doing the job(30:09) Why Ali says we're entering the "Post-Training"(31:34) Enterpret - Enterpret turns feedback noise into Customer Intelligence, so your team knows exactly what to fix and build next. Head to http://Enterpret.com/twist to book a demo and see it in action.(33:32) Understanding the value of your company's data and using it to get better outputs(41:14) Mikey calls Suno the “GLP-1s of the music industry”: everyone uses it but no one admits it(46:39) Mikey Talks break out AI artists like Xania Monet(49:32) Questions raised about how AI will effect job markets(54:43) How AI and robotics will unlock new jobs and opportunities(58:48) Possible solutions to the AI and automation question.(01:04:03) Technology's communication problem and how to fix it.(01:05:24) Are people replacing their friends with AI?(01:08:11) How CEOs are thinking about raising young kids in the world of AI.(01:12:21) Lightning round on AI agents, workflows vs. agents(01:16:49) Trapped value in sales calls, questions, company meetings that are unlocked by AI(01:22:10) How Ali pitched the LAUNCH team outside of a Jeni's Ice Cream storeSubscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.com/Check out the TWIST500: https://twist500.comSubscribe to This Week in Startups on Apple: https://rb.gy/v19fcpFollow Jason:X: https://twitter.com/JasonThank you to our partners:(10:24) LinkedIn Ads: Start converting your B2B audience into high quality leads today. Launch your first campaign and get $250 FREE when you spend at least $250. Go to http://linkedin.com/thisweekinstartups to claim your credit.(18:36) Squarespace - Use offer code TWIST to save 10% off your first purchase of a website or domain at https://squarespace.com/twist(31:34) Enterpret - Enterpret turns feedback noise into Customer Intelligence, so your team knows exactly what to fix and build next. Head to http://Enterpret.com/twist to book a demo and see it in action.

Your liver processes over 500 tasks every single day, breaking down hormones, emotions, toxins, and stress, but most people never give it the support it needs. In this episode, I sit down with Chelsea Gaul, a natural health practitioner and co-founder of InnerBrew Coffee, to discuss why coffee enemas should be part of your wellness routine.  Beyond being another detox mechanism, coffee enemas are powerful tools for clearing brain fog and releasing stored anger. Chelsea and I talk about the mechanism behind coffee enemas and how they stimulate bile release, why traditional Chinese medicine views the liver as the body's anger center, and how frequency-imprinted coffee can enhance detoxification.  Chelsea explains why pregnant women, people taking GLP-1 medications, and those struggling with constipation, nausea, or fatty liver disease should consider this therapy. She shares practical tips for beginners and explains why the emotional release that happens during a coffee enema is just as important as the physical detox.   "If your body is vibrating at a higher level, the parasite quite literally does not need to feed off you anymore. It will just leave." ~ Chelsea Gaul   In This Episode: - Why coffee enemas are a game-changer for detox - The mechanism of coffee enemas and bile release - Relieving detox symptoms with coffee enemas - Coffee enemas for anxiety, depression, and brain fog - How coffee enemas help treat liver issues - Frequency-imprinted coffee and plant integrity for efficacy - Sourcing high-quality coffee from Papua New Guinea - How coffee enemas cured Chelsea's daughter of PMS - Constipation relief and digestive benefits of coffee enemas - Relieving nausea and constipation with coffee enemas - Coffee vs. water enemas and chamomile alternatives   Products & Resources Mentioned: InnerBrew Coffee: Available in one-pound, two-pound, and five-pound options with educational videos on their website. Visit https://innerbrewcoffee.com  Puori PW1 Whey Protein and Creatine+: Use code WENDY at https://puori.com/wendy for 20% off. Tru Energy Lip Peptide Treatment: Buy one, get one free for a limited time at https://trytruenergy.com/wendy3  Organifi Happy Drops: Use code MYERSDETOX for 20% off at https://organifi.com/myersdetox  Chef's Foundry P600 Cookware: Get an exclusive discount at https://deals.chefsfoundry.com/black-friday-b?utm_term=MyersDetoxXmas  Heavy Metals Quiz: Check your score at https://heavymetalsquiz.com    About Chelsea Gaul: Chelsea Gaul is a natural health practitioner specializing in bioresonance therapy and family medicine, with a focus on helping women navigate pregnancy, the postpartum period, and chronic health challenges. After experiencing a health crisis following open-heart surgery and an autoimmune diagnosis, Chelsea discovered the power of coffee enemas, frequency medicine, and emotional detoxification. Alongside her husband Frank, she co-founded InnerBrew Coffee to provide high-quality, frequency-imprinted coffee for enemas. Chelsea and Frank live in Missouri with their six children and are passionate about making holistic health accessible, affordable, and profoundly transformative.  Learn more at https://innerbrewcoffee.com    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

Hour 2 for 12/18/25 Drew and Elizabeth pray the Chaplet of Divine Mercy (1:00). Then, Registered Dietitian Nutritionist Annie McKenna covers eating well during the holidays (26:09), GLP-1s (39:26), exercise (42:08), and sleep (46:52). Link: https://mycatholicdoctor.com/resources/doctors/annie-mckenna-ms-rdn-ldn/

In this info-packed episode, Dr. Linda Bluestein sits down with cardiologist Dr. Alexis Cutchins, an expert in pelvic venous disease (PVD) and POTS (postural orthostatic tachycardia syndrome), to tackle one of the most misunderstood vascular conditions in complex patients. From treatment options and expected outcomes to what really happens after embolization procedures, they unpack the physiology and the myths. Plus, they dive into GLP-1 medications like semaglutide and tirzepatide, long COVID symptom overlaps, heat intolerance, and why certain movement strategies backfire for patients with hypermobility, POTS, and other connective tissue conditions. They also trade tips on hydration, travel, pelvic support, and how to build movement back into your life, even when your nervous system fights you at every step. Takeaways: Dr. Cutchins explains how PVD impacts the whole body, causing fatigue, pelvic pain, and even mimicking other disorders. Weight loss drugs like semaglutide and tirzepatide can help, but only in the context of a larger strategy that considers joint instability, hormonal shifts, and gut function. They discuss how patients with PVD or dysautonomia are especially sensitive to warm environments and what that teaches us about blood flow and pressure regulation. From favorite exercises to subtle red flags, they explore how to reintroduce movement without triggering crashes or setbacks. Compression, salt loading, movement timing, and cooling tools can turn a nightmare trip into a manageable one. Want more Dr. Alexis Cutchins? https://www.instagram.com/drcutchins/ https://youtube.com/@DrCutchins?si=pNvR2A6eFOL4vS9m Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

If you're exhausted, craving everything, lifting weights, and still wondering why nothing is changing… this episode is for you. I'm sitting down with Dr. Aleksandra Gajer, an ER physician who left traditional medicine to focus on what actually helps women over 40 feel better: metabolic health, hormones, and peptides. We talk about what peptides really are (no, not steroids), why GLP-1s cracked the door open, and how midlife women can use these tools safely to support energy, sleep, recovery, muscle, and brain health without shortcuts or sketchy internet nonsense. Today's conversation is not about biohacking. It's about gaining clarity for women who are tired of being told "everything looks normal." What We Cover · Why unexplained fatigue is so common after 40 What peptides actually do in the body Why weight loss resistance ramps up in perimenopause Estrogen dominance, cortisol, stress, and belly fat made simple Why muscle is the real anti-aging strategy Peptides that support: · Energy Sleep Recovery Body composition Why peptides don't work if your lifestyle is a hot mess The danger of buying peptides from random dudes on Instagram What peptide "stacking" really means Brain health, anxiety, and what's coming next When it's time to run labs even if your doctor says you're "fine" Work With Dr. Gajer Website: theguyerpractice.com Instagram: @thegajerpractice https://the-gajer-practice.mykajabi.com/drgajer-nwlc-program-waitlist Youtube: http://www.youtube.com/@TheGajerPractice We would love people to sign up for consultations If this episode clicked for you, screenshot it, share it, and tag your biggest "ohhh that makes sense" moment. That's how better conversations spread. Facebook group https://www.facebook.com/groups/fitgirlmagic Tik Tok @kimbarnesjefferson Instagram https://www.instagram.com/kimjeffersoncoach/ Free Resources: https://www.fitgirlmagic.com/freeresources_podcast 12 week strength training program –Strong by Spring https://kimbarnesjefferson.lpages.co/strong-by-spring Website: http://www.kimbarnesjefferson.com

In this 2025 Year in Review solo episode of Derms and Conditions, host James Q. Del Rosso, DO, reflects on the standout conversations, clinical insights, and new formats that shaped the series over the past year. Dr Del Rosso opens by highlighting the launch of Tea with Dr. D, a sister vodcast that brings expert discussions to video, incorporating slides and procedural footage. He spotlights an episode with HS expert Lauren Lam, MD, who walks through comprehensive hidradenitis suppurativa management from patient check-in through long-term care. He also reviews Spilling the Tea with Dr. D, a hybrid audio-video mailbag format that addresses listener-submitted clinical questions. He then revisits key moments from the core Derms and Conditions series, beginning with Michael Payette, DO, who discussed building a dedicated HS clinic, collaborating with nondermatology providers, and his early adoption of GLP-1 agents for inflammatory disease management. Additional highlights include an episode with E. James Song, MD, on modern nb-UVB phototherapy units and practical guidance for safe implementation, as well as a unique discussion with Clay Cockerell, MD, JD, on estate planning considerations for physicians. Vitiligo emerged as a recurring focus in 2025, with expert insights from Seemal Desai, MD, and Pearl Grimes, MD, covering disease assessment, treatment timelines, topical ruxolitinib, oral therapies, phototherapy, and running a dedicated vitiligo center. Dr Del Rosso also revisits episodes on extended-release minocycline for rosacea, oral JAK inhibitors in older adults, challenging case-based discussions, evolving approaches to photoprotection and skin care counseling, and emerging therapies across alopecia areata, hyperhidrosis, tyrosine kinase 2 inhibition in psoriasis, and chronic hand eczema, including a recent FDA approval. Tune in to the full episode for a look back at a year of clinically relevant education aimed at supporting dermatologists in everyday practice.

Jason Calacanis is the host of the All-In Podcast, This Week in Startups, co-founder of the Launch Accelerator, and the “3rd or 4th investor in uber”.We go inside the origins of All-In, how they decide what to talk about each week, and if Jason thinks it helped swing the election.We also talk lesson from starting 7 media companies over the past three decades, what he's learned from studying the world's best interviewers, joining Sequoia's first scout program, his investing strategy at Launch, the story of being the “3rd or 4th investor in Uber", what people underestimate about Elon, and what it was like inside the Twitter buyout in 2022.Thank you to Austin Petersmith for helping brainstorming topics for the conversation.Thanks to Numeral for supporting this episode. It's the end-to-end platform for sales tax and compliance. Try it here: ⁠https://www.numeral.com⁠Timestamps:(3:34) Interviewing lessons from Oprah, Charlie Rose(6:48) How to ask good questions(12:20) Jason's favorite upcoming podcasters(17:57) Starting 7 media companies(22:50) How he'd start a new media company today(27:56) In-person experiences, “Bang Bang” in Japan(32:44) Vinyl bars, smartphones, mental health(38:41) Origin of the All-In Podcast(42:58) All-In's influence on the 2024 Election(46:58) Why All-In got so political(52:35) Media lessons from Trump(55:01) Joining Sequoia's very first scout program(57:55) Jason's VC investing strategy(1:03:55) How Launch competes with other accelerators(1:08:46) Fundraising is a numbers game(1:13:06) Investing in Uber and Robinhood Seed rounds(1:18:31) Origin of “3rd or 4th investor in Uber” meme(1:20:57) How Jason got the first Model S(1:26:19) What people underestimate about Elon(1:27:37) Inside the Twitter takeover(1:31:44) Career advice for young people(1:35:22) Jason's experience taking GLP-1's(1:40:05) How All-in picks topics each weekReferencedHowie: ⁠https://howie.com/⁠All-In Podcast: ⁠https://allin.com/⁠Bret Easton Ellis (Podcast): ⁠https://www.breteastonellis.com/podcast⁠Red Scare (Podcast): ⁠https://en.wikipedia.org/wiki/Red_Scare_(podcast)⁠Preet Berrara (Podcast): ⁠https://cafe.com/stay-tuned-podcast/⁠Adam Friedland Show: ⁠https://www.youtube.com/c/TheAdamFriedlandShow⁠The Insider (Movie): ⁠https://www.imdb.com/title/tt0140352/⁠Launch: ⁠https://www.launch.co/⁠Ro: ⁠https://ro.co/⁠Follow JasonTwitter: ⁠https://twitter.com/Jason⁠LinkedIn: ⁠https://www.linkedin.com/in/jasoncalacanis/⁠Follow TurnerTwitter: ⁠https://twitter.com/TurnerNovak⁠LinkedIn: ⁠https://www.linkedin.com/in/turnernovak⁠Subscribe to my newsletter to get every episode + the transcript in your inbox every week: ⁠https://www.thespl.it

Apply for coaching here00:00 Introduction and Client Questions03:02 Understanding Portion Sizes and Gender Expectations06:23 The Truth About Anti-Inflammatory Diets08:27 Sleep Adaptation and Its Effects10:29 Creatine Use During Breastfeeding13:53 Caloric Deficits and Metabolic Adaptation15:58 The Role of SAD Lamps17:58 GLP-1 Drugs: Pros and Cons21:52 Navigating Social Meals and Caloric Balance25:44 Protein Timing and Hormonal Balance27:36 Sticking to a Caloric Deficit29:44 Priorities for Overweight Individuals32:24 Structuring Effective Workouts34:21 The Value of Fiber Supplements

You will not believe this story... Let's talk about the state of GLP-1s and how to handle it. Let's connect: Mallory's Instagram & Tiktok Free Community Work With Me Submit Podcast Requests

In this episode of Correct Opinions, Trey, Katie, and Derek dive into love languages, with a heavy focus on words of affirmation—why some people desperately need them, why others struggle to give them, and how that disconnect plays out in marriage, friendships, and even stand-up comedy. From Christmas gifts that are just compliments, to cringey praise, to the realization that love is often shown in ways we don't naturally receive, this turns into an unexpectedly honest (and funny) relationship counseling session. Plus, Christmas cards, touring thoughts, insurance rants, and a few bonus correct opinions to wrap it all up. See Trey live! visit http://treykennedy.com/tour Go to http://RO.CO/CORRECTOPINIONS Ro's Insurance Checker lets you know if you're covered for GLP-1s—for free. No paperwork, no hassle, no waiting on hold. VISIT http://FUNCTIONHEALTH.COM/TREY Own your health for $365 a year. That's a dollar a day. Learn more and join using our link or use gift code TREY25 for a $25 credit towards your membership. Subscribe to the channel: https://www.youtube.com/channel/UCL3ESPT9yf1T8x6L0P4d39w?sub_confirmation=1   Subscribe to Correct Opinions on Apple: http://bit.ly/COPodcast

When coming off weight loss medications, how can you prevent your appetite from surging? Also, how can you keep the weight off? In this episode, I explore with Dr. James Hill what really keeps weight off for good. We break down why the strategies that help you lose weight are not the same strategies that help you maintain it, especially in the era of GLP-1 medications. Together, we uncover the science-backed habits and mindset shifts that can help you create a lifestyle that supports your healthiest, happiest self for life. Dr. James Hill is a world-renowned obesity researcher who's spent over 40 years studying how people lose weight, and more importantly, how they keep it off. He's the co-founder of the National Weight Control Registry and author of a new book that helps people transition off GLP-1 medications without regaining weight, all delivered with his signature clarity, compassion, and common sense. What you'll learn: (05:01) Why only about 20% of people keep weight off long-term and why this number may be even lower. (08:19) Why weight loss and weight maintenance require completely different strategies. (11:22) How GLP-1 medications have changed the landscape by helping more people finally reach their goal weight. (12:17) The three pillars of long-term weight maintenance: appetite management, physical activity, and mind state. (14:38) Why pairing high protein intake with resistance training helps protect muscle and improves metabolic health. (22:22) How “mind state” influences your ability to overcome setbacks. (31:26) Why successful maintainers average around 12,000 steps a day and schedule one hour of planned exercise daily. (35:30) The early signs of weight regain. Love the podcast? Here's what to do: Subscribe to the podcast. Leave a review. Text a screenshot to me at 813-565-2627 and wait for a personal reply because your voice is so important to me. Want to listen to the show completely ad-free? Go to http://subscribetojj.com Click “TRY FREE” and start your ad-free journey today! When you're ready, enjoy the VIP experience for just $4.99 per month or $49.99 per year (save 17%!) Full show notes (including all links mentioned): https://jjvirgin.com/hill Learn more about your ad choices. Visit megaphone.fm/adchoices

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

You lost the weight — but are you prepared for what comes after?You did it.You lost 50, 70, 100 pounds or more. And that accomplishment deserves to be recognized for what it is: life-changing, hard-won, and deeply personal. But for many people, massive weight loss doesn't end with celebration. It begins a new chapter — one few are warned about.In this episode of Plastic Surgery Uncensored, Dr. Rady Rahban breaks down the aftermath of massive weight loss — not from a cosmetic lens, but from a biological, physical, and psychological one. Why excess skin happens. Why some areas deflate while others sag. Why no two bodies respond the same way, even after the same amount of weight loss.This is not about vanity.It's about function, comfort, confidence, and health. Dr. Rahban explains what happens to skin elasticity after extreme stretching, why loose skin can feel more frustrating than the weight itself, and how excess tissue can affect mobility, hygiene, intimacy, and self-image — even as blood pressure improves, diabetes resolves, sleep improves, and energy returns. Whether your weight loss came from diet and exercise, bariatric surgery, or medications like GLP-1s, the reality is the same: massive weight loss often requires aftermath planning. That means understanding priorities, budgeting responsibly, choosing the right surgeon, preparing nutritionally, and setting realistic expectations around recovery, scars, and outcomes.It's for anyone considering weight loss, currently in the middle of it, or standing at the finish line wondering what comes next. Because success isn't just losing the weight.It's knowing how to take care of yourself after you do.✨ If you enjoyed this episode of Plastic Surgery Uncensored:✔️ Subscribe on Apple Podcasts, Spotify, or wherever you listen.✔️ Rate & Review—your feedback helps more people find us.✔️ Follow Dr. Rady Rahban across all platforms for daily insights, behind-the-scenes, and patient education:Instagram: @drradyrahbanTikTok: @radyrahbanMDYouTube: @Rady RahbanFacebook: @Rady Rahban✔️ Share this episode with someone considering plastic surgery—the right knowledge can save a life.

Today, I am delighted to be joined by the pioneers who changed everything for me. They are Larry and Belinda Wurn, the creators of Clear Passage therapy. We are diving into a topic today that was pivotal in my own fertility journey. We're talking about adhesions, the invisible internal bonds that form after surgery, infection, or trauma, quietly disrupting your body in ways most people never suspect. They can block fallopian tubes, trigger chronic pain, cause bowel obstructions, and prevent conception, yet most women are unaware of them. After being left with a frozen pelvis and debilitating pain following surgery and radiation, doctors told Belinda she would live with pain forever. Larry and Belinda refused to accept that, and over the next 40 years, they developed a therapy that has helped about 2,000 women reverse infertility, avoid major surgeries, and reclaim their lives without drugs or surgery. Their work was game-changing for me, and I know it can help many of you, too.  Stay tuned to learn what adhesions are, how they affect fertility and overall health, and how this remarkable therapy works. Techniques to Reduce Adhesion-Related Tightness Gentle abdominal massage using light fingertip pressure over the abdomen Diaphragmatic breathing to relax the abdominal wall and support tissue glide Pelvic and hip mobility movements (slow tilts, circles, and side bends) Walking or other low-impact movement to maintain circulation and flexibility Soft myofascial stretching with long, gentle holds Light heat therapy to relax superficial tension and improve comfort Bio: Larry & Belinda Wurn Larry and Belinda Wurn are physical therapists who have spent over 40 years developing Clear Passage®️ therapy, a non surgical, drug free, hands on approach designed to reduce adhesions and restore function. Their work began after Belinda developed a frozen pelvis following surgery and radiation in 1984. When doctors warned further surgery would worsen her condition, the couple pursued extensive training and began creating manual techniques to decrease adhesions naturally. Clear Passage®️ therapy has been supported by peer reviewed research and shown to reverse infertility, reduce chronic pain, improve sexual function, and clear bowel obstructions. The Wurns train therapists internationally, with clinics serving patients across the USA and UK. In this episode: What adhesions are, and why most women never even know they have them How adhesions impact women's health and fertility Why conventional scans cannot detect adhesions How trained practitioners detect the presence of adhesions The benefits of Clear Passage Therapy over conventional treatment  The best way to schedule your Clear Passage therapy sessions for the most effective results  How to maintain the results after Clear Passage therapy Links and Resources: ⁠⁠Use code CREATINE to get 10% off Creatine Calocurb Clinical — Appetite & Craving SupportA practitioner-exclusive, plant-based supplement designed to enhance your body's natural fullness signals (GLP-1 and PYY), helping reduce cravings and calorie intake. Available only through clinics such as the Integrative Health and Hormone Clinic.Visit us or order here: ⁠https://ihhclinic.com/ Guest Social Media Links: Clear Passage Physical Therapy on Facebook   Clear Passage Physical Therapy on Instagram   Clear Passage Physical Therapy on YouTube   Relative Links for This Show: What physicians are saying about Clear Passage® and the Wurn Technique® Follow Your Longevity Blueprint  On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online   Follow Dr. Stephanie Gray  On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast

In this special year-end episode of The Health Advocates, host Steven Newmark takes a step back to review several of the most significant public health developments of 2025.The episode covers major leadership changes at the U.S. Department of Health and Human Services, key meetings and votes of the Advisory Committee on Immunization Practices (ACIP), ongoing challenges related to vaccine access and uptake, and continued debates over prescription drug pricing, including “Trump Rx.” Steven also examines the rapid expansion of GLP-1 medications, the implementation of Inflation Reduction Act health provisions, public health workforce pressures, infectious disease monitoring beyond COVID-19, maternal health initiatives, and the evolving role of data and communication in public health.Rather than an opinion piece, this episode offers a straightforward recap of how policy decisions, advisory processes, and healthcare system dynamics shaped public health in 2025 and set the stage for the year ahead.Contact Our Host Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

This week on Real Food Stories, Heather breaks down the wild world of midlife nutrition in 2025 — from microdosing GLP-1s, oral semaglutide, and high-protein everything to cottage-cheese coffee, weighted vests, and the fiber frenzy. If nutrition felt chaotic this year, you're not imagining it.We revisit my most downloaded episodes on HRT confusion and upgrading your midlife kitchen, and she shares her own experience navigating hormone therapy around surgery — a perfect example of why women remain overwhelmed by inconsistent guidance.Underneath all the noise, one message stood out: women need clarity, strength, real food, and community.I close the episode with an invitation to join The Well Nourished Woman, her supportive space for women 40+ who want evidence-based guidance without the overwhelm.I would love to hear from you! What did you think of the episode? Share it with me :) Support the showLet's Be FriendsHang out with Heather on IG @greenpalettekitchen or on FB HERE.Let's Talk!Whether you are looking for 1-1 nutrition coaching or kitchen coaching let's have a chat. Click HERE to reach out to Heather.Did You Love This Episode? "I love Heather and the Real Food Stories Podcast!" If this is you, please do not hesitate to leave a five-star review on Apple or wherever you listen to podcasts.

Cameron discusses the critical role of leadership in medical practices, particularly in the aesthetics field. He emphasizes the importance of evaluating team performance, especially at the front desk, and the need for effective compensation and performance metrics. He advocates for regular one-on-one meetings with team members to foster communication and accountability. He also highlights the necessity of ongoing training and sales techniques to enhance patient engagement and practice culture. He concludes with a call to action for practice owners to take charge of their leadership and team dynamics to build a successful business.Listen In!Thank you for listening to this episode of Medical Millionaire!Takeaways:Leadership is crucial for the success of medical practices.High turnover may indicate leadership issues rather than team problems.Front desk staff are vital revenue generators and should be treated as such.Performance-based compensation can motivate staff effectively.Regular one-on-one meetings are essential for team dynamics.Sales training is necessary for enhancing patient engagement.Ongoing training and onboarding are critical for staff success.A positive practice culture leads to better retention and performance.Metrics and KPIs should guide decision-making in practices.Accountability is key to building a successful business.Medical Millionaire: The Blueprint for Scaling a World-Class Medical Aesthetics PracticeWelcome to Medical Millionaire, the go-to podcast for forward-thinking Medspa owners, Medical Aesthetics leaders, Plastic Surgery & Dermatology practices, Concierge Wellness clinics, and Elective Healthcare entrepreneurs who are ready to scale with intention and operate like a true, high-performing business.If you're building, growing, optimizing, or preparing to exit your aesthetics or wellness practice, this show is your competitive advantage.Hosted by Cameron Hemphill Your Guide to Sustainable, Scalable Growth Your host, Cameron Hemphill, is one of the most trusted growth strategists in Medical Aesthetics and Elective Wellness.With over 10 years in the industry, Cameron has helped scale 1,000+ practices and more than 2,300 providers, working alongside the most recognized KOLs, national brands, EMRs, tech companies, and private equity groups, shaping the future of aesthetics. From marketing to operations, from finance to leadership, Cameron brings a real-world, data-driven perspective on what it takes to turn a practice into a powerful business engine.What This Podcast Is All About: Each episode takes you behind the scenes of the fastest-growing practices in the country, revealing the systems, strategies, and mindset required to win in today's Medical Aesthetics landscape.Expect tactical insights, step-by-step frameworks, and conversations with:Industry thought leadersTop injectors & medical directorsEMR & tech innovatorsOperations expertsMarketing strategistsPrivate equity & M&A advisorsWellness and longevity pioneersThis is where aesthetics, business, technology, and wellness converge. What You'll Learn on Medical Millionaire Every week, you'll access expert guidance to help you scale profitably and predictably, including:Marketing & Brand PositioningCRM + Lead Management SystemsPatient Acquisition & ConversionEMR Optimization & Tech Stack ArchitectureSales Psychology & Consultation MasteryFinance, KPIs, and Practice EconomicsOperational Workflows & AutomationIndustry Trends Backed by Real Benchmark DataPatient Retention & Lifetime Value ExpansionMindset, Leadership & Team DevelopmentWhether you're opening your first location or running a multi-million-dollar enterprise, you'll gain the clarity and direction to grow with confidence. A Show Designed for Every Stage of Practice Growth Medical Millionaire breaks down the journey into four essential stages, showing you exactly how to move from one to the next:Startup – Build the foundation and attract your first wave of patientsGrowth – Scale revenue, expand services, and strengthen operationsOptimize – Increase efficiency, margins, and customer experienceExit – Prepare your practice for maximum valuation and acquisitionIf You're Ready to Grow, This Is Where You Start. Tune in weekly for actionable insights, expert interviews, and the exact playbooks high-performing practices use to dominate their markets. This is the podcast for Medspa owners who want more than a job; they want a scalable, profitable, industry-leading business. Welcome to Medical Millionaire.Let's build your practice into the empire it deserves to be.

Reports suggest around one-third of U.S. adults use continuous monitoring technology and health wearables…with trends showing persistent growth, especially among younger, educated, and higher-income individuals. And by providing 24/7/365, real-time data on physiological metrics like vital signs, glucose levels, and sleep patterns…continuous monitoring technology and health wearables are becoming increasingly powerful drivers of consumer behavior. And I believe this is super important, especially if you consider how more individuals began viewing themselves as consumers in the healthcare market compared to solely being patients. Also, with the help of continuous monitoring technology and health wearables…consumer healthcare has been evolving from a reactive, one-size-fits-all treatment approach to a distinctively proactive, personalized, and integrative data-led approach. Moreover, empowered by this "proactive health" mindset, consumers increasingly moving closer towards this four-way intersection of taste, convenience, nutrition, and functionality. Therefore, the most direct impact of continuous monitoring technology and health wearables is arguably the mainstreaming of the "food as medicine" philosophy. When consumers receive moment-by-moment feedback on how specific foods, beverages, and dietary supplements affect their bodies…they start demanding products tailored to their unique biological needs. But maybe the most significant example would be glycemic responses detected by continuous glucose monitors. In fact, whether boosted further by the recent FDA clearance for over-the-counter continuous glucose monitors and/or the rising usage of GLP-1 drugs for weight management…heightened interest in blood sugar management has also expanded beyond the diabetic community. Obviously, “war” had been waged on sugar a long time ago…but a “MAHA-influenced marketplace” has slightly shifted, with consumers being more comfortable with sweetness that has natural connotations. Either way, this signals a potentially powerful opportunity for packaged food and beverage companies to embrace diabetic-friendly products (for general wellness), as it's reasonable to imagine a similar adoption trajectory of gluten-free beyond those with celiac disease. Nonetheless, nearly 43% of consumers (today) associate healthy food with boosting performance, which means real-time data has increased demand for ingredients with measurable impacts, such as adaptogens for stress relief and nootropics for cognitive performance. Also, this influx of high-frequency biometric data can help shorten the product development cycle by providing functional CPG companies with "real-world evidence" that was previously unattainable. Next, these health technology wearables have opened a new engagement approach like how seeking to better reach the increasingly influential variations of the “wellness maxxing” internet community, marketers of functional CPG brands have begun showcasing wearable data in social storytelling to help prove product efficacy. While I totally understand the primary business cases involve premium positioning strategies…I'd bet that begins to change, as industry forward-thinkers recognize synthesizing this data into actionable low-cost, high-impact functional product solutions for broader populations is the REAL prize. Lastly, while continuous glucose monitoring revolutionized diabetes care…the same approach applied to inflammatory proteins could transform care for autoimmune diseases or other chronic diseases (i.e. cardiovascular health).

Dr. Rudy Eberwein shares his personal journey from eating heavily processed foods in the US to becoming a nutrition-focused doctor, highlighting how American foods are engineered to activate reward centers in the brain. He explained that his medical training barely covered nutrition, despite it being his undergraduate major, leading him to establish a weight loss clinic in 2005 to focus on disease prevention rather than just treatment.Key Takeaways from this discussion include:GLP-1 medications are considered a major medical breakthrough for weight management, comparable to penicillinVisceral adipose tissue (VAT) is an active endocrine organ that produces inflammatory cytokines, increasing disease riskThe combination of GLP-1 medications and testosterone therapy can be highly effective for weight management and muscle preservationMaintaining muscle mass while losing fat is crucial for healthy aging and metabolic health93% of Americans have at least one component of Cardiokidney Metabolic Disease (CKM)Endocrine-disrupting chemicals in food and plastics negatively impact hormone balance and metabolismSelf-love and positive mindset are essential components of any health transformation journeyDr. Rudy shared his comprehensive approach to wellness using the BEST LIFE acronym.B: Baseline (know your starting point)E: Evaluate (get comprehensive testing)S: Sit with a specialist (find the right medical team)T: Take action (implement changes)L: Lean into your tribe (find community support)I: Investigate again (retest to track progress)F: Fine-tune the program (make adjustments)E: Evolve into the new person (embrace your transformation)Dr. Rudy Eberwein is an internal medicine physician with an impressive academic and professional journey. Despite excelling in an acute care hospital setting, Dr. Rudy's passion for preventive medicine led him to open a weight loss clinic with his wife called A New You Wellness, where he has helped thousands of patients lose weight and improve their health.Learn more at DrRudyBestLife.com and check out his podcast TheBestLifeCode.com Visit ConfidenceThroughHealth.com to find discounts to some of our favorite products.Follow me via All In Health and Wellness on Facebook or Instagram.Find my books on Amazon: No More Sugar Coating: Finding Your Happiness in a Crowded World and Confidence Through Health: Live the Healthy Lifestyle God DesignedProduction credit: Social Media Cowboys

Nearly 30 million Americans are living with sleep apnea, yet many go undiagnosed. On this episode of The Mark White Show, Dr. Kuljeet (Kelly) Gill, a neurologist and sleep medicine specialist with Northwestern Medicine, explains the warning signs of sleep apnea, why symptoms are often overlooked, especially in women, and what happens during a sleep study. She also discusses popular sleep trackers, viral trends like mouth taping, and when weight loss or GLP-1 medications may help reduce risk. A timely conversation for anyone struggling with fatigue or poor sleep.

Too busy to read the Lens? Listen to our weekly summary here! In this week's episode we discuss…Black, Asian, and Hispanic patients were more likely to have delays in initiation of treatment of nAMD.Patients taking GLP-1 receptor agonists had a 51.7% reduced risk of developing non-infectious uveitis.Implanting multifocal intraocular lenses in children showed improved visual acuity and stereopsis compared to a standard intraocular lens.

In this episode, Dr. John Barnes welcomes Lindsay Venn, PA-C, RD, MPH—a clinician with rare dual training in medicine and nutrition, and a founding member of the Society of Metabolic Health Practitioners. Lindsay shares her journey into integrative, root-cause metabolic care and the mission behind Venn Integrative Medicine, her multi-state telehealth practice.Together, John and Lindsay unpack the science and real-world implications of insulin resistance—what it is, why it's so widespread, and how it drives a long list of symptoms and chronic conditions. Lindsay explains how IR develops, why it's often not your fault, and how conventional dietary guidelines contributed to the modern metabolic crisis.They also explore why insulin resistance shows up differently in women's health, influencing everything from PCOS and fertility to the hormonal transitions of perimenopause and menopause. Lindsay breaks down the key labs and biomarkers she evaluates in clinical practice (A1C, fasting insulin, glucose patterns, hormone profiles) and why fasting glucose alone is not enough to assess metabolic health.The episode wraps with a grounded discussion of GLP-1 medications—their potential role, their limitations and concerns, and how people can boost their own GLP-1 production naturally with low-carb/keto nutrition, specific supplements, and  lifestyle strategies.If you want a clear, compassionate, clinically grounded explanation of insulin resistance—and why women are uniquely affected—this is an episode you won't want to miss. 

Katie Couric flips the script on Jen and Pumps.Order our new book, join our Substack, and more by clicking here: https://linktr.ee/ivehaditpodcast.Thank you to our sponsors:Apretude by Viiv Healthcare: Learn more at https://APRETUDE.com or call 1-888-240-0340.Shopify: In 2026, stop waiting and start selling with Shopify. Sign up for your one-dollar-per-month trial and start selling today at https://shopify.com/haditProlon: Just visit https://ProlonLife.com/HADIT to claim your 15% discount and your bonus gift.RoBody: Go to https://RO.CO/HADIT to see if your insurance covers GLP-1s—for free.Branch Basics: Get 15% off Branch Basics with the code Hadit at https://branchbasics.com/Hadit #branchbasicspodFollow Us:I've Had It Podcast: @IvehaditpodcastJennifer Welch: @mizzwelchAngie "Pumps" Sullivan: @pumpspumpspumpsSpecial Guest: Katie Couric ⁨@KatieCouric⁩ See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the confusion around fasting and hormones isn't because the science is complicated, but because most people are using the wrong tools for the wrong goals? In this episode, I sit down with Dr. Mindy Pelz to get clear about what fasting actually does, when it helps, and when it backfires. This is a conversation about taking ownership of your metabolism instead of chasing trends that don't match your life. We talk about the viral moment from her Stephen Bartlett interview, how misinformation spreads, and what she learned from being at the center of it. Mindy breaks down her six core fasts, why women need a different strategy, and how to adjust your approach if you train hard. We get into cycle-based fasting, fertility, menopause, HRT, toxic load, peptides, creatine, apple cider vinegar, and the rise of GLP-1 drugs. If you've ever wondered how to use fasting without wrecking your energy or performance, this episode will give you a clearer path forward. Dr. Mindy Pelz is a bestselling author, educator, and functional health expert known as the fasting guru. Her books Fast Like a Girl and Age Like a Girl have helped millions of women rethink metabolic health, hormones, and aging, and she has led hundreds of thousands of people through community fasts that focus on real-world results, not quick fixes. What We Discuss: (00:00) How a Misquote Went Viral and Changed Mindy's Career (04:12) What the Internet Got Wrong About Testosterone and Fasting (11:19) The Biggest Fasting Mistakes Most People Still Make (17:05) The Six Core Types of Fasting and When to Use Each (23:28) Fasting for Gut Repair, Weight Loss, and Dopamine Reset (28:54) How Athletes and Active Women Should Adapt Their Fasts (34:04) Cycle-Based Fasting and Hormonal Timing for Women (43:00) Supplement Cycling, Autophagy, and Metabolic Flexibility (55:19) GLP-1 Drugs, Gut Health, and the Real Drivers of Hunger (59:31) The Long-Term Risks of Quick-Fix Weight Loss Trends (01:05:40) Fertility, Progesterone Needs, and Rethinking HRT (01:16:14) Menopause, Brain Rewiring, and Building Cognitive Strength (01:28:48) Peptides, ACV, and Final Insights Before Wrap-Up Thank you to our sponsors: Therasage: Head over to therasage.com and use code Be Bold for 15% off Air Doctor: Go to airdoctorpro.com and use promo code HUSTLE40 for up to $300 off and a 3-year warranty on air purifiers. Magic Mind: Head over to www.magicmind.com/jen and use code Jen at checkout. Momentous: Shop this link and use code Jen for 20% off Manna Vitality: Visit mannavitality.com and use code JENNIFER20 for 20% off your order Prolon: Get 30% off sitewide plus a $40 bonus gift when you subscribe to their 5-Day Program! Just visit https://prolonlife.com/JENNIFERCOHEN and use code JENNIFERCOHEN to claim your discount and your bonus gift. Amp fit is the perfect balance of tech and training, designed for people who do it all and still want to feel strong doing it. Check it out at joinamp.com/jen Find more from Jen:  Website: www.jennifercohen.com Instagram: @therealjencohen   Books: www.jennifercohen.com/books Speaking: www.jennifercohen.com/speaking-engagement Find more from Dr. Mindy Pelz: Website: www.drmindypelz.com Instagram: @dr.mindypelz TikTok: @drmindypelz YouTube: @drmindypelz

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are changing medicine — but at what cost? In this episode of The Exam Room Podcast, host Chuck Carroll sits down with Ben Urich, PharmD, PhD, to break down the real-world data behind the GLP-1 explosion. You'll learn: - How many people are actually using GLP-1 drugs - Why most users stop — and why that's starting to change - The true cost of GLP-1 medications to employers and health plans - Common and serious side effects to be aware of - Why GLP-1s are now being studied for Alzheimer's disease and addiction - What the future holds as more than 30 new drugs enter the pipeline This is a must-watch conversation for anyone considering GLP-1 medications, currently using Ozempic or Wegovy, or wondering where modern weight-loss medicine is headed next.

Check your testosterone levels: https://www.manual.co/smith I help small businesses make money online: https://www.jamessmith.business Try Neutonic: https://www.neutonic.com/jamessmith Free trial: Online coaching app: https://www.affordableonlinecoaching.com Scientist and author Dr. Andrew Steele joins James Smith to tackle the problem with aging and why dying of “old age” might one day be seen as a preventable condition. Andrew breaks down the science of longevity, the myths around “anti-aging,” and the difference between fundamental research and influencer nonsense. He explains how new medical breakthroughs could help humans live healthier for far longer, but also why the hype around biohacking and “forever pills” is getting dangerously ahead of the science. They explore the ethical, political, and even economic implications of extending human life, from billionaire-funded immortality labs to the fear that longevity could deepen inequality. Andrew reveals what the real science shows about genes, lifestyle, and luck; why exercise is still the best anti-aging treatment we have; and how new drugs like GLP-1 agonists could transform global health and longevity. He explains: ◼️ Why 90% of deaths in rich countries are caused by aging ◼️ The truth about genetic luck vs lifestyle choices ◼️ How longevity drugs could revolutionise healthcare ◼️ Why “anti-ageing” influencers are misleading the public ◼️ The shocking economics of living to 100… or beyond Chapters 00:00 Why Men Die Earlier Than Women 01:31 The Real Problem With Aging 02:36 Separating Longevity Fact From Fiction 05:23 What Your Face Reveals About Health 08:50 How Much Do Genetics Actually Matter? 12:32 Do Weight Loss Drugs Slow Aging? 16:48 The Stigma Of Weight Loss Drugs 19:01 James' Experience Taking Weight Loss Drugs 22:37 Is Taking Ozempic "Cheating"? 27:02 The Reality Of Maintaining Weight Loss 31:26 Why Modern Diets Are Failing 35:26 The Future Of Longevity Medicine 39:36 Will Longevity Increase Retirement Age? 43:01 The Problem With Bryan Johnson's Protocol 46:44 Is Biohacking Just An Eating Disorder? 52:01 The Dangers Of Over-Optimizing Health 56:36 Does Health Anxiety Shorten Lifespan? 01:01:46 The Truth About HRT For Women 01:06:51 Does Testosterone Shorten Men's Lives? 01:12:50 Why Eunuchs Live Longer Than Men 01:17:56 The Philosophy Of Living Forever 01:27:11 The Most Effective Longevity Habits 01:29:56 Does Intermittent Fasting Increase Longevity? 01:38:36 The Most Promising Anti-Aging Drug 01:45:36 The Economic Case For Curing Aging Welcome to "The Problem With" where each week we look into a problem to get a better understanding of it. This podcast has no sponsors, only my businesses and investments. Please check out the links below. I'm on a mission to help men check their levels of Testosterone, more info here: https://www.manual.co/smith I help small businesses make money online: https://www.jamessmith.business Please check out and try Neutonic here: https://www.neutonic.com/jamessmith For a free trial of my online personal training app go here: https://www.affordableonlinecoaching.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

GLP-1 medications, TRT, and peptides are becoming common—but they don't change the rules of strength training. Learn how GLP-1s and strength training work together to preserve muscle, manage recovery, and train intelligently for long-term health. In this episode of Beast Over Burden, hosts Niki Sims and Andrew Jackson unpack how GLP-1 medications, TRT, and peptides are changing the coaching landscape—and what that means for strength training. Drawing from years of hands-on coaching experience, Andrew explains how GLP-1s and strength training interact, why muscle preservation becomes critical during rapid fat loss, and how tools like TRT can accelerate progress without changing the core rules of adaptation. If you're a lifter training on GLP-1 medications, considering TRT, or a coach working with clients using these tools, this episode delivers a first-principles framework for protecting muscle, managing recovery, and training for long-term health. What You'll Learn in This Episode How GLP-1s and strength training interact in real lifters Why training on GLP-1 medications increases the need for muscle preservation Common fatigue, nutrition, and recovery challenges with GLP-1s How TRT affects recovery, training frequency, and progress Why first principles still apply—even with hormone support How coaches should think about programming for clients on GLP-1s or TRT The role of protein, resistance training, and bone density during rapid fat loss Why communication between lifter and coach matters more than ever How peptides fit into recovery—and where their limits are Why long-term quality of life should guide training decisions Timestamps 00:00 – Intro: Niki & Andrew set the stage 02:10 – The biggest shift Andrew has seen in 10 years of coaching 04:30 – What counts as hormone-influencing tools (GLP-1s, TRT, peptides) 07:20 – Why GLP-1 medications reduce appetite—and what that changes 10:45 – Training on GLP-1s: fatigue, low energy, and muscle loss risk 14:30 – Fat loss vs muscle preservation: why strength training matters 18:05 – TRT and strength training: the return of linear progress 22:40 – Recovery, frequency, and why TRT doesn't remove limits 26:15 – Peptides, recovery, and optimization myths 30:10 – Coaching clients on GLP-1s: why honesty matters 34:25 – Nutrition priorities when appetite is suppressed 38:10 – Bone density, muscle mass, and aging well 42:00 – First principles that never change 46:00 – Final thoughts: tools don't replace training 48:10 – How to work with a Barbell Logic coach Key Takeaway GLP-1s, TRT, and peptides may change the training landscape—but they don't change the map. Strength training, protein intake, recovery, and intelligent coaching still determine long-term results. PS - IF YOU'RE INTERESTED IN TAKING ONLINE COACHING FOR A TEST RUN, CHECK IT OUT HERE.    Connect with the hosts Niki on Instagram Andrew on Instagram Connect with the show Barbell Logic on Instagram Podcast Webpage Barbell Logic on Facebook Or email podcast@barbell-logic.com

If you or someone you know is experiencing suicidal thoughts, emotional distress, or a mental health crisis, call or text 988, or chat via 988lifeline.org. Support is available 24/7. You are not alone, and help is available.Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comDr. Gabrielle Lyon sits down with renowned medical correspondent and OB/GYN, Dr. Jen Ashton, for a profoundly personal and candid conversation about navigating life's most intense tragedies while maintaining a public career.Dr. Ashton bravely opens up about the devastating suicide of her first husband, a world-class surgeon, 18 days after their divorce was finalized. She shares the raw reality of being in clinical shock and how the immense tragedy became an unexpected catalyst for post-traumatic growth.Dr. Ashton, who holds a Master's degree in Nutritional Sciences, also brings her medical expertise to current health debates:The Power of Fitness: Learn how resistance training became Dr. Ashton's lifeline to snap her out of emotional numbness and shock.The Hormone Misinformation Crisis: They discuss the flawed data and flawed media that led to 20 years of women being under-treated for menopause after the Women's Health Initiative (WHI).GLP-1 Myths: Dr. Ashton breaks down the top myths surrounding GLP-1 medications, the difference between absolute vs. relative risk, and the non-weight related benefits that are just beginning to emerge.The Problem with Extremes: They address the societal tendency to seek out quick-fix solutions in health, menopause, and obesity care, arguing that the true sweet spot is in a nuanced, moderate position.Finding Love Again: Dr. Ashton shares the unexpected miracle of finding profound love with her current husband, legendary sports executive and TV producer, Tom Werner.About Jen Ashton: Retiring stiff paper gowns and unrelatable medical advice, Dr. Jennifer Ashton, a Board-certified Ob-Gyn, author, and TV medical correspondent, breaks the barrier between doctor and patient. Affectionately referred to as your all-in-one ‘BFF'/Ob-Gyn, Dr. Jennifer Ashton marries an unparalleled medical background with an accessible‘girl's-girl' attitude. Though Dr. Ashton can easily speak to the latest beauty and fashion trends, this Ivy League graduate means business when it comes to women's health.Thank you to our sponsors: Timeline - Get 20% off your order at https://timeline.com/LYON OneSkin - Get 15% off with the code DRLYON – https://www.oneskin.coFind Jen Ashton at: Book: Life After Suicide - https://a.co/d/0HvOeSHIG:

In this episode, I reconnect with my friend, fitness expert, and midlife wellness coach, Natalie Jill. The last time we had a conversation on the show was eight years ago, and a lot has changed since then. Natalie has not only evolved her brand, but she has completely transformed the way she approaches health, aging, performance, and mindset. This is a powerful and honest conversation about what it really means to live a healthy life at any age, especially through midlife. Natalie shares how she shifted from being known for general fitness and fat loss to becoming a leading voice in midlife wellness, hormone health, and aging with intention. We talk about what sparked that transition, how she redefined her mission, and why being deeply interested in your work is the key to any sustainable transformation. She opens up about navigating the overwhelming amount of information in the health space, and how midlife can be a confusing season where symptoms change, metabolism shifts, and the old tools don't always work anymore. We dive into biohacking, natural wellness, supplements, and the role of personalized nutrition. Natalie explains why you have to become your own health detective and why cookie-cutter fitness programs often fail women and men navigating midlife. We also get into the complexities of hormone replacement therapy, how to think through GLP-1 medications, and why sleep might be the most underrated performance enhancer of all. One of the things I've always admired about Natalie is her ability to evolve and reinvent herself without losing authenticity. We discuss the pressure of showing up online, the struggle to post consistently, controversial content, and how to stay aligned with your mission even when the internet has its own opinions. This is an empowering, honest, and deeply practical conversation for anyone looking to take ownership of their health, find passion in their work again, and embrace midlife with clarity and confidence. In This Episode, You'll Learn: How Natalie Jill reinvented her brand and why midlife wellness became her mission Why midlife requires new strategies for nutrition, metabolism, and fitness How to cut through the noise in the health and wellness industry The role of biohacking and simple daily habits that actually make a difference Sleep strategies that improve energy, recovery, and overall health The truth about GLP-1 medications like Ozempic and who they are really for What most people misunderstand about hormone replacement therapy How to stay authentic and consistent in content creation Why passion, curiosity, and reinvention are essential at every stage of life How to approach midlife with empowerment instead of fear

Dr. Daryl Gioffre is a highly sought-after gut health and inflammation specialist with over two decades of experience in the field. Having overcome a life-long sugar addiction, in addition to his own gut and mold toxicity issues, he knows firsthand what it takes to overcome adversity and challenges in the pursuit of superior health. In addition to running the successful Alkamind brand, he is the founder of Kick Acid Enterprises, a virtual nutritional testing and coaching platform focusing on getting to the root cause of inflammation by restoring, balancing and strengthening the microbiome, what he calls GutFitness. This episode Heather and Dr. Daryl drill down on all things around Leaky Gut plus tips to heal symptoms.    He is also a board-certified chiropractor, Reiki Master, certified raw food chef, and author of the best-selling books Get Off Your Acid, and Get Off Your Sugar: Burn the Fat, Crush Your Cravings, and Go From Stress Eating to Strength Eating. Dr. Gioffre has appeared on ‘Live with Kelly and Ryan', Good Morning America, Access Hollywood, The Doctors, Extra, E News, People Magazine, Vogue, Daily Mail, Page Six, and more to discuss his Acid-Kicking approach to health and fitness. He is a passionate motivational speaker and currently sits on Fran Drescher's Cancer Schmancer Medical and Wellness Advisory Board. Offer from Dr. Gioffre: His website: https://www.getoffyouracid.com/pages/about-dr-daryl Link to the gut testing kits: https://www.drdaryl.com/labs61812613 use code HEATHER15 for a 15% discount on checkout. Same for Alkamind products. Use code at checkout HEATHER15 for 15% discount off all products. Website: www.heatherthomson.com Social Media: IG: https://www.instagram.com/iamheathert/                     You Tube: https://youtube.com/@iamheathert?si=ZvI9l0bhLfTR-qdo SPONSOR:  LifeMD  -  LifeMD is offering a Holiday and New Year's Sale with 50% off their Weight Management Program plus free shipping, which makes getting started easier and more affordable. Just visit lifemd.com/INMYHEART  to activate the offer. Disclosure: Read all warnings before using GLP-1s. Side-effects may include a risk of thyroid c-cell tumors. Do not use GLP-1s if you or your family have a history of thyroid cancer. SPONSOR: CROWD HEALTH:  This open enrollment, take your power back. Join CrowdHealth to get started today for $99 for your first three months using code INMYHEART at www.JOINCROWDHEALTH.COM.   CrowdHealth is not insurance. Opt out. Take your power back. This is how we win.  Learn more about your ad choices. Visit megaphone.fm/adchoices

What No One Tells You About Life After GLP-1 Meds GLP-1 medications like Ozempic, Wegovy, and Mounjaro have changed the game for weight loss—but what happens when the prescription ends and you need a plan? This week, I'm joined by Dr. Jim Hill, leading obesity researcher and architect of the National Weight Control Registry, to uncover what really happens after GLP-1s—and how to maintain your results without spiraling into regain. We'll explore the three types of weight regain, what makes maintenance so different from weight loss, and why your body is capable of mimicking GLP-1 effects naturally—if you know how to support it. Whether you're on these meds now, thinking of stopping, or just want to protect your progress, this is a must-listen.

Midlife can feel like a perfect storm—menopause, stubborn weight gain, bone loss, shifting identities, and an unexpected rise in loneliness. In today's episode of Asking for a Friend, we're digging into one of the most overlooked drivers of women's health in their 40s, 50s, and 60s: disconnection—and why rebuilding community may be as powerful as lifting heavy or optimizing your hormones.My guest, Terry Tateossian, is a Harvard-trained, ISSA-certified personal trainer, nutritionist, emotional-eating coach, hormone specialist, and founder of THOR: The House of Rose Retreats, where hundreds of midlife women have transformed not just their bodies—but their confidence, connection, and sense of purpose.We talk about:Why loneliness is the new smoking for women in midlifeHow community improves metabolic health, adherence, motivation, and emotional resilienceTerry's personal transformation from obesity, burnout, and hospitalizations to becoming a leader in women's wellnessThe recurring struggles she sees in midlife women—under-eating protein, chronic dieting, hormone confusion, and the pressure to stay smallHow retreats create safety, belonging, and joy—often sparking lifelong friendshipsThe smallest, simplest steps you can take today to feel less aloneWhy lifestyle foundations matter more than ever—protein, strength training, stress reduction, and nervous system regulationIf you've been feeling isolated, stuck, or unsure how to reconnect with the adventurous, vibrant woman you used to be, this conversation is going to speak straight to you.You can find Terry Tateossian at:https://www.thehouseofrose.com/womens-wellness-retreats/https://www.instagram.com/thor.wellness/ https://www.instagram.com/how.good.can.it.get/_________________________________________1:1 health and nutrition coaching or Faster Way - Reach me anytime at mailto:mfolanfasterway@gmail.com If you're doing “all the right things” and still feel stuck, it may be time to look deeper. I've partnered with EllieMD, a trusted telehealth platform offering modern solutions for women in midlife—including micro-dosed GLP-1 peptide therapy—to support metabolic health and longevity. https://elliemd.com/michelefolan - Create a free account to view all products. ✨ Sign up for my weekly newsletter: https://michelefolanfasterway.myflodesk.com/i6i44jw4fq

Make America healthy again: is that helping the food-as-medicine movement or hurting it? And why is it so important to focus on quality food as medicine- which means nutrient density and real quality- rather than settling for simply “more fruit and vegetables”? Why would you, if you can, deny people with severe diabetes and lower incomes the best-quality food possible, especially when it has the biggest ripple effect?Today, a check-in conversation with Erin Martin, one of the leaders advancing the food as medicine movement in the US. It has been an exciting, interesting, and challenging few years — from speaking on the Hill in Washington, to passing a food as medicine act in her home state of Oklahoma (which has some of the worst health crises in the country), to scaling their program of prescribing produce to reverse type 2 diabetes to over 500 patients. But also: politics, making America and children healthy again, a global and local health crisis spiralling out of control, GLP-1 drugs breaking through, and somehow food and regenerative agriculture becoming polarising, a political minefield.So much to talk about: the first social impact bond, which isn't a bond but an outcome-based payment scheme,  is coming in early 2026 in Oklahoma. And super important: real data is showing massive savings when it comes to prescribing healthy vegetables, fruit, and cooking classes.More about this episode.==========================In Investing in Regenerative Agriculture and Food podcast show we talk to the pioneers in the regenerative food and agriculture space to learn more on how to put our money to work to regenerate soil, people, local communities and ecosystems while making an appropriate and fair return. Hosted by Koen van Seijen.==========================

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezRo - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________           This isn't medical advice — always talk to your doctor before making any health decisions.In this episode, we discuss the complexities of obesity, moving far beyond the simple "calories in, calories out" narrative. Our conversation unravels the latest science to distinguish between different types of obesities (e.g., metabolically healthy vs. unhealthy, visceral vs. subcutaneous fat distribution), challenging the perception of obesity as a single, uniform condition. Experts in obesity medicine and educators, we examined the landscape of collegiate obesity and nutrition education of future leaders. We dive into how the landscape of obesity treatment is being introduced to new students and practitioners. Our experts contrast modern, holistic, and evidence-based approaches with past didactic methods, emphasizing metabolic health, patient empathy, and anti-bias training.Our astute educators help Debunk GLP-1 Myths as well. A critical segment is dedicated to dismantling the misconception that weight loss on GLP-1 agonists (like Ozempic or Wegovy) is simply due to calorie restriction alone. Our experts explain the drug's mechanisms involving satiety signals, gastric emptying, and metabolic pathways, proving it is a complex hormonal and neurological intervention.Don't miss this important episode, and learn how the future of obesity treatment is being shaped.Professional Guest:Leah D. Whigham, PhD, FTOSProfessor, Department of Nutritional SciencesDr. Nik DhurandharPaul W. Horn Distinguished ProfessorHelen DeVitt Jones Endowed ChairChair, Department of Nutritional SciencesAssociate Dean for Innovation, College of Health and Human SciencesTexas Tech UniversityCheck out Dr Dhurandhar's Fat-loss Diet book at the below linkhttps://www.amazon.com/Dhurandhars-Fat-loss-Diet-Nikhil-Dhurandhar/dp/9352770307______________________________________________________________________Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Retatrutide is years away from FDA approval and yet the fight over access, price, control of this medication is already well underway. That's what this podcast is going to be about today. There's well over a hundred thousand people by my estimates who are already on some form of this medication today. And that should tell you enough about how disruptive this molecule is and will be. It is a game changer among game changer. We've been talking about it for three years here at On The Pen, well before any of your favorite gym bros were talking about Retatrutide. We were talking about Reta, who tried Retatrutide here at On The Pen. And that's because we identified this triple agonist as a game changer among game changers. So This is going to be a very Retatrutide heavy episode, and so I hope you'll join us and stick with us if this is a topic you enjoy, because I think this is really going to effectively lay the groundwork for what accessibility to this medication will look like. So let's get into it. Welcome to the On The Pen Podcast with your host, Dave Knapp. Welcome to the On The Pen, the weekly dose podcast. This is our weekly roundup in incretin memetic news. And frankly, there's no news that is bigger than Reta-Trutide news. Just find me any news that is bigger than the data that we got on Reta-Trutide. Now, we already did a video about the Triumph Phase II clinical trials that we got in osteoarthritis of the knee. You can go back and check out that video if you'd like more data. So we're not gonna super... rehash the data. We'll go over at a high level what the data showed us. We're not going to go over how the medicine works, because by now we all know that it's the triple agonist, right? If terzapatide was a dual agonist, GLP-GIP, Retatrutide is the triple agonist that adds to it a glucagon component, which is absolutely just shredding, shredding liver fat. It is absolutely revving up people's metabolism and showing a tremendous amount of weight loss. So let's get into what the weight loss looked like in this first trial, because there are longer obesity trials where, where the primary outcome is the weight loss this was again a specific trial in measuring pain reduction in folks with osteoarthritis of the knee but check out these numbers these are placebo adjusted meaning it's taking the two percent out that people lost on placebo but looking at these numbers Folks on one milligram over forty eight weeks lost seventeen percent. They bumped up to four milligrams. Those folks lost twenty two percent. So right there at the lowest dose, you're already reaching the efficacy of today's drugs that are on the market, like triseptide and semaglutide in their various forms. If you bumped up to eight milligrams, you saw twenty four percent placebo adjusted weight loss and at twelve milligrams, twenty six point four percent weight loss. Adding back in that two percent of the placebo that those on placebo loss, that's twenty eight point four percent weight loss in these forty eight weeks at the highest dose. When you adjust for some of the more real world outcomes, you kind of ding the numbers a little bit based upon people who quit the drug, et cetera. Those numbers look more like a twenty percent weight loss and twenty three point seven percent weight loss at the highest dose. But even then, you're still seeing a drug that is better than the current drugs that are on the market. around forty eight percent of patients on Retatrutide lost greater than twenty five percent. And then if you were at that twelve twelve milligram dose, that highest dose patients lost fifty nine percent of patients lost more than twenty five percent of their body weight. There was a subset that lost thirty percent of their body weight and some even over thirty five percent of their body weight on Retatrutide. So the lower doses compete with today's best drugs and the upper doses are entering into bariatric surgery level weight loss. And that's putting the whole obesity system on notice and probably a lot of surgeons nervous because typical body weight loss was something like the street sleeve gastrectomy. For example, it's about eighteen to twenty five percent body weight. The Roux-en-Y gastric bypass twenty five to thirty five percent weight loss or the duodenal switch thirty to forty percent weight loss. So the upper doses of Ritutrutide overlap with sleeve and bypass outcomes without any surgery. It's incredible. It is a game changer among game changer. It is the new benchmark in obesity medicine. And there's actually more data, like I said, landing in later twenty twenty six. The longer duration will historically, if history is a marker, equal more weight loss than we even see here at this forty eight weeks. We have an interview that will be airing later this week on our channel and on our podcast with our friend Mimi from Australia who just wrapped up her clinical trial on Retatrutide. They ended it like ten weeks early on her, which was a huge bummer to her. So we're going to hear from her because she had to end abruptly. We're going to hear her story, an incredible story. She's one of those folks that got up that thirty five percent body weight loss in the time that she was on Retatrutide. So, this is just showing you that these drugs are not simply an alternative to bariatric surgery. We are approaching a point in time where these are on par with bariatric surgery, and as people are on this Reta-Trutide trial, you see that these numbers aren't plateauing either. So we will see stronger weight loss numbers the longer that these folks are on this trial. And I think you'll see some of those numbers in that population of folks on the higher doses eclipse maybe even some of what we see with some of these bariatric surgeries. the real story that i think is taking shape here is not in how powerful Retatrutide is because we've literally been expecting or anticipating this kind of data for more than three years at on the pin we've been talking about this and i think that's sort of reflected in the fact that you didn't see this massive spike in eli lilly stock wall street was expecting this as well Um, so it was on par, I think with expectations, but the expectations are astronomical compared to previous options that were available to patients and all the innovation in the world. All of these drugs, we talked at last week about WV, E double Oh seven, the James Bond of weight loss that targets fat, not only targets fat loss, but it also targets the promotion of building of, of lean muscle mass. We're talking about an insane future in obesity medicine. But none of it means anything if people can't access it. And that's really where we are today in terms of ensuring that there's going to be an option for everyone. And that's sort of what I want to get into today, because Lilly wants Retatrutide to be classified as a biologic, so not a traditional small molecule drug like you've seen every other incretin and nutrient-stimulated hormone-treating obesity on the market to date. They're trying to get this classified as a biologic. Now, we talked about this before on the podcast. That matters in three major ways. It affects the exclusivity length of time that a pharmaceutical company has on a drug. That goes from, I believe, five years of market exclusivity to twelve. It affects compounding rules because biologics cannot be compounded. And then that gives the pharmaceutical companies a tremendous amount of pricing power in the marketplace, because essentially there's no competition and there's no competition for a long time. But this whole argument about getting this classified as a biologic is not about safety. It's about protection and we're going to get into it. So let's explain this here. This is why Retatrutide really is not a biologic arguably. So biologics are large proteins. There are hundreds of or even thousands of amino acids grown in living cells that are sensitive to tiny manufacturing changes. Retatrutide is a short chain peptide. It's chemically synthesized and it is below the traditional biological size thresholds when it comes to how those things are defined. We'll just leave it at that. So even though it acts like a biologic in the body, it's made like a drug. It's made like a small molecule drug. And if it's treated as a drug, they get, like I said, five years of market exclusivity. Now, really a lot of confusion around what this means, but essentially the first five years of the life of a drug, the patent can be challenged for a number of reasons. We've seen patent challenges right now are going on in the courts for both semaglutide and terzepatide. But these companies are guaranteed that five years of market exclusivity, no matter how those patent lawsuits shake out. That five years jumps to twelve years with the biologic. So ultimately, there's no biosimilars that are allowed during that twelve year window. Again, with terzapatidin and semaglutide, it's five years. They could lose their market exclusivity within five years of the release of the patent. twelve years with a biologic. So if they lose their patent challenges on Trezabitide, they still have some time left with market exclusivity for the drug. They likely will not lose those, but that jumps to twelve years. And I think the most important thing to understand about the reclassification of Reta-Trutide to a biologic would mean that, 503A and 503B pharmacies are effectively locked out of compounding this medication, 503Bs would have some latitude arguably, but they would face extreme barriers. Routine compounding becomes legally and technically restricted because biological status doesn't slow compounding down. It actually shuts the door or almost completely shuts the door. Biologics not only would allow Lilly to have longer market exclusivity, no compounding, but it would allow them to command a higher price in the marketplace because A, they get this designation and there's an assumption when they bring this to market that they're harder to manufacture, that they're harder to copy, that there are fewer negotiating alternatives for payers. They can command a higher price with the insurance companies, and the price pressure stays muted for much longer because, again, you don't have those pressures of compounding. You don't have the pressures externally from lawsuits that could end your market exclusivity in that first five years of the drug's existence. So there's just a lot of price pressure upwards on a biologic compared to a normal small molecule drug. And when there's no credible alternative or backup option, which to Retatrutide, there wouldn't be, it'd be the first drug that has bariatric surgery level results. The prices won't come down. They'll command a massive price and the prices won't come down. So let's talk about where this currently stands because ultimately the Eli Lilly went to the FDA. We've been covering this for well over a year, maybe close to two years now, a year and a half at least. Lily went to the FDA, they said, we want this classified as a biologic, here are the reasons why. The FDA initially said, no, we're not gonna do that. So Lily challenged that decision in court. So the point that we're at today is the court told the FDA to reconsider and better explain itself So the first no given to the FDA to Lilly didn't stick. The courts looked at it and they said, you need a better, you need to reconsider your decision and you need to explain your decision better to Lilly. So ultimately we're sitting now at the point where the court has made its decision that the FDA has to go back and now we await basically what the FDA has to say on this. But if this thing is classified as a biologic, that would be a massive massive loss for patients. Now, again, we're, we're focusing on the accessibility of this drug into the future. And, and I think that this is an important conversation to have. One of the interesting points that I have to bring into the conversation is the fact that I got to sit in on a, on a closed session question and answer with the media. I didn't get to answer or, excuse me, excuse me, ask a question at this time, but shortly after the most favored nations announcement, with eli lilly and the trump administration in the oval office that day there was a press briefing that i was invited to dave ricks was asked by max bayer reporter of endpoints who we've interviewed here on this very podcast and he was asked was Retatrutide included in the most favored nations discussions meaning will we get a cash pay version of Retatrutide uh that is you know circumventing the pbms uh will we get these cheaper prices will will it be be two hundred fifty dollars also and there was a hard no there was a hard no like no that was not included that was not part of these discussions even though what we heard from the trump administration was that those these companies that were jumping on to the most favored nations agreement were also agreeing to offer future drugs at most favored nations pricing now was lily saying that no they're not going to offer it at the it wasn't part of the negotiations in terms of the price points that they had discussed for triseptide maybe or did it mean altogether there won't be a cash pay option of this medication i don't know um that we would love to get clarity on But I highly doubt we're going to get any more information than necessary at this point in time. So, Reta-Trutide is being positioned to be a drug that, and well so, should be offered at a premium. This is a drug that is far exceeding the current drugs that are on the market. I think that we're gonna see even the indications of Reta-Trutide far beyond simple obesity, but it is going to be their crown jewel for the next decade, more than likely. Reta-Trutide is going to be a massive drug, and so they're attempting to build a moat around it. And these are things that we need to be aware of as a community so that we can hold our positions and conversations about these and basically, you know, be able to articulate to people in positions of power like this is an important thing to us. This is an important thing in the advocacy of obesity and sort of the next frontier of the fight of accessibility, which marches on. each and every day because of course the current drugs, while as great as they are and as much as access is expanding, there are still people with sicker or rather more advanced versions of metabolic disease that are gonna need these newer treatments and price is going to be a huge factor. So let's talk about the gray market right now because I think it's also nearly impossible to talk about this topic without including a discussion about the gray market because there are, as I mentioned at the outset, hundreds of thousands of people on this medication already. So research grade Retatrutide exists. It's in the gray markets of the Internet. It's where people are going and they're buying, you know, basically versions of these these peptides that are made in factories overseas. They're being imported into the United States, oftentimes illicitly in shipments that are marked as something else. The FDA has tried to crack down. There's no doctor involved in this. It's a very, that's why it's called the gray market, right? So it's not a prescription medicine, but the demand for this is massive. And all you have to do is really scroll your TikTok for about fifteen minutes. You're going to come across a insane amount of content on the topic of Retatrutide. An insane amount of, and oftentimes, you know, what I find most disturbing is oftentimes it looks like very young people. very young people taking Retatrutide. Crazy, it's crazy. But the demand is massive and there's a whole gray market for it proliferating over on TikTok and in the far reaches of the internet. And I would estimate that tens, if not hundreds of thousands of people are already or have already used it. And I think it's a testament to a to to the effectiveness of this drug. It's also a testament to the fact that there needs to be more guardrails, I think, around this stuff than there currently is, because gray markets appear and they thrive when legal access lags the reality of the demand for the medication. And you saw this earlier this week as we launched a petition to fight back against the Safe Drug Act of twenty twenty five, a drug, a drug act that is in theory designed to put guardrails around compounding. But in practice, I think is creating a new battlefield for Eli Lilly and Novo Nordisk to shut down compounding on the current classes of medications, which is why We as a community need to be loud about our opposition to it. If they were really concerned about the safety of compounds, they would do two very simple things. They would require reporting around the active pharmaceutical ingredient of a compound. Patients ought to be able to know where the actual source of their medication is coming from. And they should know that those places are FDA approved and inspected. And the second thing is they should require adverse event reporting. Those are required of 503Bs. They should be required of 503As as well. 503As are making a tremendous amount of money. They're making thousands and thousands of these scripts. So when there are adverse events, they should be required to report those to the FDA. Simple. None of that is in this bill. None of it. None of it. Instead, it seeks to put caps on the amount of compounds that can be made by a compound pharmacy without them having to report to the FDA. And then it seeks to codify the definition of essential copy. Again, all of these things that will become law and then argued in court and then a battlefield for Lilly to potentially win a legal battle and thwart compounding. It's creating a new battlefield for them. They're losing in the courts. They're losing with the current language that exists in the Food, Drug, and Cosmetic Act. So we create new language. We create new law. Just vague enough to pull some threads and hopefully win something in court. That's how I see it. You may see it differently. If you do, curious to hear from you. But if you want to fight back against this legislation, you can go to otplinks.com and fight back against that. piece of legislation, because I think that we need as a community to have our voices heard on this, especially those who have gotten healthier by way of compounded medications. So the rumor on the gray market, to get back and close the thought loop here, There's been no specific FDA cutoff announced, but what the rumors going around are that that the compounded versions of GLP ones, especially obesity medicine in the gray market, are all going to turn off like a sieve on January first. Now, I seem to feel like this is probably more of a marketing tactic by these companies to sell a whole bunch of peptides at the end of the year. I think that's probably creating some panic and probably panic buying on people's parts. And so these companies are benefiting greatly. Again, that's why there should be guardrails around this. There's no guardrails around this at all. I mean, at the end of the day, they can say whatever they want to say, so long as they cloak everything in research grade. And these rumors proliferate around and people spend thousands, tens of thousands of dollars. I've heard of people having twenty years worth of Retatrutide in their freezer. Why? For what purpose do you need that? So just a massive amount of money made in this gray market. And that's not to knock people who use it. I say this all the time, but I think it's worth qualifying the statement. It's not knocking people who use it. I get it. But at the same time, we're talking about an industry that is, there's no altruism here. They're in it for money just as much as Eli Lilly is, except they have actually done nothing in the way of advancing medicine. They've just taken intellectual property, copied it, and sold it to you with a label that says, don't put this in your body. So you know where I stand on the gray market. I've heard from many people who've been injured by gray market stuff. It's just what it is. It's a gray market. You're taking your health into your own hands. Please, whatever you're doing out there, as risky as it may be, please involve your doctor and let your doctor know what you're doing so you can be monitored for the things your doctor believes you should be monitored for if you're using this. But this all underscores, again, the need for accessibility to these medications, the need for us to be aware of the fact that a moat is already being built around the most advanced metabolic drug in the pipeline. And we just need to be aware so that when it comes time to fight, we're all ready and informed. And that's what this podcast is serving to do. Before we jump into the next topic, I do want to thank our sponsor, our headline sponsor of this podcast. is a company called Shed. Now, if you are looking for access to care for obesity, then look no further than our partners at Shed who believed in this podcast enough to help us do it full time. You can go to Trished.com and use code OTP25 to save twenty five percent at Trished.com, where you're going to get connected to a doctor who will when medically necessary prescribe medication to treat your obesity. You also get access to coaching. You'll get access to all sorts of medication, whether it's the branded or the compounded versions, depending on your specific situation. All of it is available at Trished.com. They use one of my favorite compound pharmacies in the game, Strive Pharmacy, which I've gotten the chance to dig into on my own. I really love what they do there. They're a It functionally operates a lot more like a 503B. Uh, and I think that they're doing great work over at a strive pharmacy. They partner with shed. So I just love this, this, and when we were looking for somebody to offer a compounded versions, I wanted to make sure that I trusted the pharmacy. People always ask me, Dave, who, who should I go to? I'm like the pharmacy matters more than anything because you want to trust the source of your medication. So try shed.com use code OTP25. Listen, you're going to want to learn about taking any new medication before you take it. Learn about the potential side effects. Learn about the trade offs. There's no free lunch, but all of the information that you're going to need, you can find it. Try shed.com and be familiarizing yourself with all of your options there. So thank you to Shed for being a wonderful partner here at On The Pen. Now let's talk about some data that dropped. We're talking about accessibility and all of the sort of advancements in the world mean very little if people can't access it. That's why I think this data that dropped this past week from our friends over at Rowe is incredible. Absolutely game changing data. So check out this data. Real world telehealth data looking at sixty eight weeks. This is looking at patients who were enrolled in their row body program and on a GLP one specifically some maglutide mean weight loss in this study looked at again patients in over sixty eight weeks. The mean weight loss was sixteen point six percent on average. Thirty three percent of patients lost more than twenty percent and the safety in this study and looking at this data match the clinical trials. So what we're seeing here is that care for obesity can be delivered through a telehealth platform at scale and match clinical trial results. So that scalability decides how many people get access. There are not enough doctors out there to serve the over hundred million people in the United States living with overweight or obesity. so when you hear these blowhard doctors online calling all telehealth platforms except their own a pill mill or as i like to say pin mill the data is actually showing something quite different in that this type of obesity care can be delivered at scale through telehealth platforms it can meet people where they're at and allow people to get care without the shame, without the stigma, without their doctor just pointing to the door and saying, if you want a GLP-I, get out of my office. I ain't going to get it here. How ridiculous. But these people can go to platforms like Rho or Shed or any number of telehealth platforms that are out there and not only get access to medicine, but get access to care. So of course, not all telehealth companies are created equal. Of course, not all compound pharmacies are created equal. You want to do your homework and all of that. But this is data that shows that This kind of care can be delivered at scale via a virtual platform and show similar results to a clinical trial. I think, and this is peer reviewed data, and I think that this is just absolutely great news because when we talk about the problem, we need scalable solutions. The old brick and mortar ain't going to work when you don't have enough doctors to serve enough patients. If we want to get life-changing treatments like ritatratide or terzapatide, semaglutide, whatever, into the hands of the people who need it the most, we need companies to innovate scalable tech platforms that can meet patients where they are, that can leverage current technologies to find people the care that they need. And in this case, it's access to a doctor. It's access to a platform. It's access to prescription medication when appropriately prescribed. And it can be done, and it is being done. So I think this is great news, and will play a huge part in the future. As we talk about Retatrutide, even though it's a year and a half away, maybe a little bit longer, it's already exposing – the issues around accessibility and pricing. Hopefully there will be compounded versions available if they're medically necessitated, if there are shortages. We hope that the battleground for that is not already set and won by Lilly before this drug even comes to market. But there are strategies being done to keep people boxed out But I can tell you that whatever happens with Retatrutide, the future of obesity medicine is in virtual care. And platforms are rising to the occasion. Retatrutide hasn't reached patients yet, but it's already forcing the system to show us, you know, are you ready? Are you ready to deliver bariatric surgery level results at scale to the people who need them? So I am so thankful that you joined me here on this podcast today. Again, we love to talk about we're at a Retatrutide. If you're interested, we've been going live every Monday, Wednesday and Friday at eleven a.m. Central Time here on our YouTube channel, on our tick tock, on our X platform. We're doing that because there's enough news to bring you just about every single day. And we've been doing it for the last couple of weeks. If you've enjoyed it, let me know in the comments of the video on YouTube. Send me an email at David on the pen dot com. Uh, so every single Monday, Wednesday, Friday, and then we do a weekly rundown of the obesity medicine news every Tuesday. That's what this is. The weekly dose podcast. You can catch this on all of the platforms that you listen to your podcasts on, and please make sure to leave us a five star rating and review before you log out of your podcast app. That helps so much. I don't think you guys understand how much that helps, uh, the work that we do here to just train the podcast algorithms that this one is worth listening to. I hope you enjoyed today's podcast. If you did, drop it a thumbs up, five-star review, subscribe on YouTube, do all the things. Thank you for being here, and thank you for being the best part of what we do. We will catch you on the next one. Thank you, my friends. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Can you get rhabdomyolysis (rhabdo) from taking GLP-1 medications like Ozempic, Wegovy, and Mounjaro(tirzepatide)? Here are the reports of people getting rhabdo after taking these medications, including how much they took, how high their creatine kinase level were, and what happened. Rhabdo after taking glucagon-like peptides appears to be rare but this is still a side effect people should be aware of. View the video below to see the reports yourself.Referencehttps://youtu.be/NlLTIsXJ860 Read My Rhabdo BookAmazon https://amzn.to/4aRPnu4 (affilate link) Consultations https://supplementclarity.com/private-consultations/  Connect With MeaffiliateSupplementClarity.comYouTubeTiktok   About  I've been sorting nutrition facts from fiction since the 1990s and helping people understand dietary supplements, using clinical research as my litmus test. I am unbiased. I analyze the research so you don't have to.  I wrote the first book about exercise-induced rhabdomyolysis.I have an MS in exercise science and a BS in biology & chemistry.   Disclaimer Episodes are for information only. I'm NOT a medical doctor. NO medical advice is given or implied. ALWAYS consult your physician for the best health advice for you. I participate in theAmazon Associates program which means if you click on a link to amazon and make a purchase, I may make a small commission at no extra cost to you.

Obesity readouts continue to be hot for biotech with new top-line data from both injectable and oral therapies pushing the boundaries on efficacy. On the latest BioCentury This Week podcast, BioCentury's analysts break down last week's readouts from Eli Lilly, Structure  and Wave Life Sciences, and discuss a deal in the space by Pfizer.Lilly reported the latest for its triple agonist contender retatrutide for best-in-class weight loss, while strong Phase IIb data put Structure back in the oral GLP-1 race. Meanwhile, Pfizer added an oral GLP-1R agonist via a deal). Structure and Wave parlayed their data into follow-on cash, as did Kymera after posting data for its STAT6 program KT-621 that hints at a new era for degraders in immunology.The analysts then detailed the results of BioCentury's industry sentiment survey on FDA, which found that politicization of the agency's leadership, volatility and uncertainty are casting a long shadow over investor and drug developer sentiment. Finally, they discuss the impact of the congressional stalemate over the U.S. Small Business Innovation Research (SBIR) program.View full story: https://www.biocentury.com/article/657880#ObesityDrugDevelopment #TargetedProteinDegradation #STAT6 #FDARegulation #SBIRFunding00:00 - Introduction01:45 - Obesity Data12:17 - Kymera's Breakthrough21:45 - FDA Survey Results29:41 - SBIR Funding StalemateTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Tom Hulick sees Eli Lilly (LLY) leading the GLP-1 race and evolving healthcare race, noting the company's retatrutide drug as an example. He explains how the company's developments play into a larger economic story and the "MAHA movement." Tom White offers an example options trade for Eli Lilly. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

In this episode, I sit down with fat activist, author, podcaster, and feminist, Virgie Tovar. We cover:Virgie's experience growing up in a fat family and how that shaped her early relationship with her bodyFat activism vs body positivity & the evolution of these frameworks The intersection of queerness & fatness, & the having your heartbroken by the culture The ethics of GLP-1's and prescribed starvationGLP-1s as a pump an dump marketing cyclingHow to cope with feeling the pressure of going on a GLP-1 for weight lossLiving a life of integrity vs a life of  apologyMore From Virgie: Virgie's websiteVirgie's SubstackA 5 Stage Model of Fat Identity DevelopmentMore From Leah:

SPONSORS: - Don't miss out on all the action this week at DraftKings! Download the DraftKings app today! Sign-up using https://dkng.co/bears or through my promo code BEARS - Protect your family with life insurance from Ethos. Get your free quote at https://Ethos.com/BEARS - Head to https://DRINKAG1.com/BEARS you'll get the welcome kit, a Morning Person hat, a bottle of Vitamin D3+K2, a AG1 Flavor Sampler and you'll get to try their new sleep supplement AGZ for free. - Sign up for a $1 per month trial period at https://shopify.com/bears. Christmas CAME early! The Summer Bears are now the *Winter Bears* and they have returned to phone it in and fulfill some contractually obligated laughs. Chris Distefano and Stavros Halkias invade YMH Studios to talk awful breakfast decisions, Bert's cruise from hell, fat-guy medicine science, Husky-induced life chaos, bombing on MTV, fighting GLP-1 drugs, Mike Tyson saving Big Pun at The Tunnel, and why both of them should never own pets, houses, or functioning digestive systems. It's chaotic, barely prepared, medically concerning, and absolutely perfect. Enjoy! https://www.instagram.com/stavvybaby2 https://www.instagram.com/chrisdcomedy/ 2 Bears, 1 Cave Ep. 319 https://tomsegura.com/tour https://www.bertbertbert.com/tour https://www.chrisdcomedy.com/ https://www.stavvy.biz/ https://store.ymhstudios.com Gambling problem? Call one eight hundred Gambler. In New York, call 8778-HOPENY or text HOPENY (467369). In Connecticut, Help is available for problem gambling. Call 888-789-7777 or visit https://ccpg.org. Please play responsibly. On behalf of Boot Hill Casino & Resort (Kansas). Pass-thru of per wager tax may apply in Illinois. Twenty-one plus age and eligibility varies by jurisdiction. Void in Ontario. Restrictions apply. Bet must win to receive Bonus Bets which expire in 7 days. Minimum odds required. For additional terms and responsible gaming resources, see https://DKNG.co/audio. Limited time offer. Chapters 00:00:00 - Intro 00:03:29 - Slutty Little Breakfast 00:07:14 - Podcast Polyamory 00:14:15 - Chrissy Housing Crisis 00:21:35 - Stavros Vs Fat Guy Medicine 00:31:48 - Fat Joe, Guy Code, & Graveyard Of Failed Shows 00:46:14 - Maybe The Worst Dog Ever 00:56:17 - Geopolitical Shenanigans & NYC Mayors 01:08:11 - Wrap Up Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Dubrow names the GLP-1 that will take over 2026. Meanwhile, Heather takes a ‘jab’ at post-Ozempic beauty standards, and who is Terry telling to STFU?See omnystudio.com/listener for privacy information.

A message from a single man looking to enter the lifestyle spurs a conversation on the balance between being honest and being kind... We also talk about how single men hold other single men accountable at our events, and our thoughts on why that doesn't happen more often. Plus, big life changes are teased.... To enter the Shivers holiday giveaway, comment under the Shivers post on our Instagram, https://instagram.com/fpspodmedia or our X, https://x.com/fpswingers. Winner will be chosen next Monday, January 22nd at 8 pm PST! Get started on your peptide or GLP-1 journey by scheduling a consultation with us at https://revitaglowmeds.com To hear more about Brenna's new professional world, join our Patreon community at https://patreon.com/frontporchswingers Get a FREE month of Kasidie access! Click on the Kasidie banner at https://frontporchswingers.com Join us for an upcoming event, including our Wifey.com sponsored AVN party: https://members.frontporchswingers.com  

This week on Two Parents & A Podcast, we're joined by Laura Modi — co-founder & CEO of Bobbie — to talk through everything parents actually need to know about infant formula, without the fear, guilt, or internet panic. Laura breaks down formula in a way that finally makes sense: what it is, how it's designed to mimic breast milk, how to read ingredient labels, and which things actually matter (+which ones parents can stop spiraling about). We also get into why formulas that look nearly identical can be priced so differently, whether European formulas are really “better” than U.S. formulas, and why seed oils have become such a hot-button topic in this space. We also talk openly about recalls, safety standards, switching formulas, and the emotional weight that comes with feeding decisions — including the guilt and pressure so many parents experience when breastfeeding doesn't go as planned or when formula ends up being the right choice for their family (because feeding your baby should not feel like a moral test). If you've ever stood in the formula aisle feeling overwhelmed, gone down an ingredient-label rabbit hole, or wondered if you're “doing it right” (you are) — this episode is here to bring clarity, confidence, and a whole lot of relief (and maybe help you close 17 browser tabs). Timestamps: 00:00:00 Welcome Back to Two Parents & A Podcast!  00:00:32 Meet Laura Modi, Co-Founder & CEO of Bobbie 00:03:15 Formula 101: What It Is, How It Mimics Breast Milk & How to Read a Formula Label 00:04:50 The Top 3 Ingredients to Look for in Infant Formula  00:06:03 The Top 3 Ingredients to Avoid in Infant Formula 00:07:00 Why Formula Prices Vary (Even When Ingredients Look Similar) 00:10:17 How Formula Is Approved, Tested & Regulated in the U.S. 00:14:38 Are European Formulas Really “Better Than” U.S. Formulas? 00:17:08 Why Seed Oils Became So Controversial 00:25:00 What Infant Formula Would Look Like Without Seed Oils 00:29:09 The ByHeart Recall & How Parents Should Think About Safety 00:31:13 The Biggest Formula Myth Parents Need to Unlearn 00:35:24 When a Formula Isn't Working & How to Know It's Time to Switch 00:37:25 Feeding Guilt, Shame & Choosing What's Best for Your Baby 00:40:46 Where Laura Hopes Bobbie Will Be in 10 Years 00:42:00 Thanks for Listening! #twoparentsandapod --------------------------------------------------------------- Thank you to our sponsors this week: *Aura Frames: $35 off with code TWOPARENTS — shop perfect holiday gifts at https://on.auraframes.com/ *MasterClass: MasterClass always has great offers during the holidays, sometimes up to as much as 50% off. Head over to https://www.masterclass.com/TWOPARENTS for the current offer. *Veracity: Make the switch to GLP 1's the natural way. Head to https://www.VeracitySelfCare.com and use code TWOPARENTS for up to 45% off your order. *Magnetic Me: New customers get 15% off at https://www.magneticme.com with code TWOPARENTS. --------------------------------------------------------------- Listen to the pod on YouTube/Spotify/Apple: https://www.youtube.com/@twoparentsandapod https://open.spotify.com/show/7BxuZnHmNzOX9MdnzyU4bD?si=5e715ebaf9014fac https://podcasts.apple.com/us/podcast/two-parents-a-podcast/id1737442386 --------------------------------------------------------------- Follow Two Parents & A Podcast: Instagram | https://www.instagram.com/twoparentsandapod TikTok | https://www.tiktok.com/@twoparentsandapod Follow Alex Bennett: Instagram | https://www.instagram.com/justalexbennett TikTok | https://www.tiktok.com/@justalexbennett Follow Harrison Fugman: Instagram | https://www.instagram.com/harrisonfugman TikTok | https://www.tiktok.com/@harrisonfugman Find our guest: Website | https://www.hibobbie.com/ Instagram | https://www.instagram.com/lauraclairemodi Instagram | https://www.instagram.com/bobbie Learn more about your ad choices. Visit megaphone.fm/adchoices

Everyone is talking about Ozempic—but your heart feels torn. Is taking weight-loss medication faithful, unfaithful, wise, or giving up? In this episode, Brandice gently unpacks how to quiet the noise, release the shame, and invite the Holy Spirit into your health decisions. Whether you're considering GLP-1 medications or already using them, you'll walk away with clarity, compassion, and peace. Get your show notes: https://gracefilledplate.com/a-christian-perspective-on-ozempic/ Links mentioned: Get your Prayer for Weight Loss Toolkit For a deep dive, check out Grace Filled Plate Platinum and be sure to get on the waiting list You may also love: Breaking Up With the Scale Workshop Season 1 Episode 11: Should Christian Women Try to Lose Weight to “Look Better”? Season 2 Episode 2: What about Weight Loss Shortcuts? Season 3 Episode 14: How to Manage Your Weight Loss with Grace and Wisdom Season 4 Episode 20: A Christ-Centered Approach to Self-Love and Weight Loss Get a FREEBIE: Get your FREE Faith [is greater than] Food Jumpstart

Larry is joined by podcast host Jon Lovett for a wide-ranging conversation on the current state of the world. They discuss Trump, Democratic frontrunners, health care, Lovett's personal experience with GLP-1 medications, and much more. Host: Larry WilmoreGuest: Jon LovettProducers: Devon Renaldo and Brandy LaPlante Learn more about your ad choices. Visit podcastchoices.com/adchoices